Caspase 8 plays a dual role in the survival of T lymphocytes. Although active caspase 8 mediates apoptosis upon death receptor signaling, the loss of caspase 8 activity leads to receptor-interacting protein (RIP)-1/RIP-3-dependent necrotic cell death (necroptosis) upon TCR activation. The anti-apoptotic protein c-FLIP (cellular caspase 8 (FLICE)-like inhibitory protein) suppresses death receptor-induced caspase 8 activation. Moreover, recent findings suggest that c-FLIP is also involved in inhibiting necroptosis and autophagy. It remains unclear whether c-FLIP protects primary T lymphocytes from necroptosis or regulates the threshold at which autophagy occurs. Here, we used a c-FLIP isoform-specific conditional deletion model to show that c-FLIP L -deficient T cells underwent RIP-1-dependent necroptosis upon TCR stimulation. Interestingly, although previous studies have only described necroptosis in the absence of caspase 8 activity, we found that pro-apoptotic caspase 8 activity and apoptosis were also enhanced in c-FLIP L -deficient T lymphocytes. Furthermore, c-FLIP L -deficient T cells exhibited enhanced autophagy, which served a cytoprotective function. Together, these findings indicate that c-FLIP L plays an important antinecroptotic role and is a key regulator of apoptosis, autophagy, and necroptosis in T lymphocytes.
1
The homodimerization of pro-caspase 8 in the DISC leads to autocatalytic cleavage and the generation of active caspase 8, which in turn triggers the downstream activation of caspase 3 and eventually leads to apoptosis. 2 Two isoforms of c-FLIP protein have been identified in mice: the 24-kD c-FLIP R and the 55-kD c-FLIP L . Both isoforms form heterodimers with procaspase 8 to inhibit its activation. 2 However, when dimerized with c-FLIP L , pro-caspase 8 is partially activated and cleaves c-FLIP L to create molecules with signaling capacity, such as p43FLIP. 3 In contrast, because of lack of pro-caspase 8-like C-terminal domains, c-FLIP R solely functions to inhibit caspase 8 activation, and the formation of c-FLIP R -procaspase 8 heterodimers does not result in pro-caspase 8 cleavage.
2 c-FLIP L and c-FLIP R are both expressed in mature T lymphocytes, and the expression of either isoform is sufficient to protect resting T cells from apoptosis. 4 Necroptosis is a form of receptor-interacting protein-1/ receptor-interacting protein-3 (RIP-1/RIP-3)-dependent programmed necrotic cell death that is induced when caspase 8 activation is suppressed in embryonic and hematopoietic cells. 5 Previous reports suggest that c-FLIP L is involved in the regulation of necroptosis. c-FLIP L protects cIAP antagonisttreated cells from Fas-induced cell death, which involves both apoptosis and necroptosis. 6 c-FLIP L inhibits the formation of the cell death-inducing 'Ripoptosome', which functions in TLR3-induced apoptosis and necroptosis. 7 Furthermore, siRNA-mediated silencing of c-FLIP L sensitizes cells to TNF-induced RIP1/RIP3-dependent necroptosis. 8 However, the role of c-FLIP L in necroptosis has yet to be studied in primary T cells in a genetically deficient model.
Autophagy plays a critical role in regulating T-cell homeostasis. 9, 10 Overexpression of c-FLIP suppresses autophagy, as c-FLIP competes with LC3 for Atg3 binding. 11 Moreover, recent studies suggest a correlation between caspase 8 inhibition and excessive autophagy. [12] [13] [14] Whether c-FLIP directly regulates autophagy or contributes to autophagy regulation by controlling caspase 8 activity in primary cells has not yet been addressed. More importantly, whether enhanced autophagy leads to necroptosis in T lymphocytes remains controversial. [14] [15] [16] Thus, the role of c-FLIP in regulating autophagy and autophagy-related cell death in primary T cells has yet to be determined.
We previously reported that c-FLIP is essential for T-cell development and survival, 4, 17 and c-FLIP L -deficient T cells failed to respond to Listeria monocytogenes infection. 18 Here, we show that c-FLIP L À / À T cells fail to proliferate upon TCR stimulation due to extensive Fas-dependent cell death. Both apoptosis and RIP-1-dependent necroptosis contribute to the loss of cellularity after T-cell activation. Interestingly, c-FLIP L À / À T cells generate more active caspase 8 (p18) than wild-type T cells, indicating that the apoptotic and antinecrotic activities of caspase 8 may be independent. In addition, c-FLIP L À / À T cells display increased induction of autophagy, which promotes T-cell survival. Together, our results identify c-FLIP L as a key regulator of apoptosis, necroptosis, and autophagy in primary T lymphocytes.
Results c-FLIP L -deficient T lymphocytes display enhanced cell death upon TCR stimulation. We previously generated conditional knockout mice lacking only the c-FLIP L isoform in T lymphocytes (referred to as c-FLIP L À / À ) and found that c-FLIP L À / À mice failed to generate effector T-cell responses against Listeria monocytogenes infection in vivo. 18 The impaired effector response in c-FLIP L À / À mice was initially attributed to defective T-cell proliferation ( Figure 1a ). Because impaired proliferation could be caused by enhanced cell death, we analyzed cell survival and found that the death rate of c-FLIP L À / À T cells upon TCR stimulation was dramatically increased when compared with that of wild-type T cells (Figures 1b and c and Supplementary Figure S1 ). Regardless of the strength of the TCR signal, a majority of c-FLIP L À / À T cells (both CD4 þ and CD8 þ ) died within 36 h of simulation (Figure 1b and Supplementary Figure S1 ). The decreased numbers of live c-FLIP L À / À T cells were apparent at o24 h after TCR stimulation, suggesting that this phenomenon was not attributable to impaired T-cell proliferation, as T lymphocytes do not divide in the first 24 h following stimulation (Supplementary Figure  S2) . In contrast to these results, c-FLIP L À / À T cells displayed no survival defects in the absence of TCR stimulation (Figure 1b Figure S4C) , suggesting that the impaired effector T-cell expansion observed upon TCR stimulation in c-FLIP L À / À mice is a secondary effect of enhanced cell death. Interestingly, when the Fas/FasL interaction was blocked, c-FLIP L À / À T cells consistently proliferated slightly faster than wild-type T cells, whereas anti-FasL mAb treatment had no effect on wild-type T-cell proliferation (Figure 2c ). These data are consistent with the fact that NF-kB signaling is increased in c-FLIP L À / À T lymphocytes. 18 Taken together, these findings indicate that the enhanced cell death observed in activated c-FLIP L À / À T cells was dependent on the Fas/ FasL interaction.
We next tested whether c-FLIP L À / À T cells displayed altered expression of death receptors or death receptor ligands. Both untreated and activated c-FLIP L -deficient T lymphocytes expressed Fas at levels comparable to those in wild-type T cells (Supplementary Figure S5A) . As FasL expression is undetectable in naive T cells, we analyzed cell surface FasL 24 h after TCR stimulation. Similar levels of FasL were observed in wild-type and c-FLIP L À / À T lymphocytes (Supplementary Figure S5B) . These results show that the enhanced Fas-dependent cell death observed in c-FLIP L À / À T cells was not due to changes in the expression of Fas or FasL.
c-FLIP L -deficient T-cell death is partially mediated through caspase-dependent apoptosis. As c-FLIP L inhibits death receptor-mediated caspase 8 activation, 2 we next investigated whether the loss of c-FLIP L led to increased caspase activity in T lymphocytes. Active caspase 8 (p18) was not detected in naive T cells regardless of c-FLIP L expression (Figure 3a) . However, after TCR stimulation, c-FLIP L À / À T cells generated high levels of active caspase 8 (p18), and blocking the Fas/FasL interaction with an antiFasL blocking antibody completely prevented active caspase 8 generation (Figure 3a) . The accumulation of pro-caspase 8 upon blockade of FasL in both wild-type and c-FLIP L À / À T cells indicated that the cleavage of pro-caspase 8 in activated T cells occurred through a Fas-dependent mechanism. In contrast, wild-type T cells do not generate significant amounts of active caspase 8 (p18), likely because c-FLIP L forms heterodimers with caspase 8 and inhibits its complete cleavage. Pro-caspase 8 levels was increased in activated T cells, likely because the catalytic activity of pro-caspase 8 is essential for the survival of activated T cells. 20 We further tested whether suppressing active caspase c-FLIP L -deficient T cells undergo necroptosis upon TCR stimulation. We then analyzed whether activated c-FLIP L À / À T cells died through necrosis. Apoptosis is characterized by the generation of mononucleosomal and oligonucleosomal DNA fragments, which are released first to the cytosol during early stages of apoptosis and then to the culture medium outside the cells at the late stage of apoptosis. 21 In contrast, necrotic cells directly release randomly digested DNA into the culture medium as they lose membrane integrity. 21 Necropoptosis and apoptosis can be induced in L929 cells by zVAD and etoposide, respectively.
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The enzyme-linked immunosorbent assay (ELISA) results confirmed that zVAD-treated L929 cells immediately released fragmented DNA to the supernatant, whereas etoposide-treated L929 cells showed a pattern of DNA release typical of apoptosis: the fragmented DNA was first detected in the cytosol before being released to the supernatant (Supplementary Figure S7) . We thus assessed the release of fragmented DNA in wild-type and c-FLIP L À / À T cells upon TCR stimulation using the same methods. The wild-type T cells displayed a fragmented DNA release pattern similar to that observed upon induction of apoptosis in L929 cells. In contrast, c-FLIP L À / À T cells quickly released fragmented DNA to the supernatant, suggesting that they were undergoing necrosis. Fragmented DNA was also detected in the cytosol of activated c-FLIP L À / À T cells, suggesting that some of the cells died from apoptosis (Figure 4a ).
Previous data suggested that c-FLIP L might recruit RIP-1 to the DISC, leading to caspase 8-dependent RIP-1 cleavage. 23, 24 Therefore, we investigated whether RIP-1 was involved in the death of c-FLIP L -deficient T lymphocytes. Autophagy is enhanced in c-FLIP L À / À T lymphocytes. A correlation between necroptosis and excessive autophagy has been observed in several previous studies. 12, 14, 25 Hence, we investigated whether the c-FLIP L -deficient T lymphocytes displayed altered levels of autophagy. During autophagy induction, LC3-I is conjugated to phosphatidylethanolamine (PE) to form LC3-II. LC3-I/LC3-II conversion in mammalian cells is a reliable marker for autophagy induction. 26 After TCR stimulation (18 h (Figures 5f  and g ). Interestingly, we observed an accumulation of membrane-containing autophagosomes in naive c-FLIP Ldeficient T lymphocytes that were entirely absent in naive wild-type cells (Figures 5f and h) . Together, these data demonstrate that c-FLIP L À / À T cells display enhanced autophagy induction, especially after T-cell activation.
Overexpression of c-FLIP protein inhibits autophagy in several cell lines. 11 However, whether c-FLIP in primary T cells has a similar effect remains unclear. We thus assessed autophagy levels in activated T cells expressing c-FLIP isoform-specific BAC transgenes (referred to as c-FLIP R -Tg and c-FLIP L -Tg). Both c-FLIP R -Tg and c-FLIP L -Tg inhibited LC3 punctum formation upon TCR stimulation; however, c-FLIP R -Tg inhibited punctum formation more efficiently than c-FLIP L (Supplementary Figure S8) . These data suggest that c-FLIP can modulate autophagy in activated T lymphocytes.
Enhanced autophagy plays a cytoprotective role in c-FLIP L -deficient T lymphocytes. Conflicting findings have been reported regarding the role of caspase inhibitionmediated autophagy in cell death. Previous studies have concluded that autophagy either causes 12, 25, 28 or protects cells from zVAD-induced necrotic cell death. 29 We therefore tested the role of autophagy in the death of c-FLIP L À / À T lymphocytes. Atg3 plays an essential role in autophagosome formation by catalyzing LC3 processing. 30 Inducible shortterm deletion of Atg3 in T lymphocytes resulted in reduced autophagy induction (Supplementary Figure S9A) but did not cause enhanced cell death under either resting or activated conditions 31 (Supplementary Figure S9B) . Therefore, we crossed c-FLIP L À / À (c-FLIP f/f x c-FLIP R -BAC Tg) mice to Atg3 f/f ER-Cre mice. In this model, c-FLIP and Atg3 are successfully deleted in vitro upon 4-hydroxytamoxifen (4-OHT) treatment. 4, 31 We found that the loss of Atg3 further decreased cell survival in c-FLIP L À / À T cells, especially upon TCR stimulation (Figure 6 ). These data suggest that autophagy plays a cytoprotective role in activated c-FLIP L À / À T lymphocytes.
Necroptosis in c-FLIP L -deficient T cells involves reactive oxygen species (ROS).
CM-H 2 DCFDA staining showed that ROS levels were slightly increased in c-FLIP L -deficient T cells under both resting and activated conditions (Supplementary Figure S10A) . The antioxidant N-acetylcysteine (NAC) partially inhibited TCR-induced cell death in both wild-type and c-FLIP L -deficient T cells. Moreover, adding Nec-1 to NAC-treated cells did not improve their survival (Supplementary Figure S10B) . Therefore, the production of ROS likely contributes to necroptosis in c-FLIP L -deficient T cells. The major cellular reservoir of ROS production is the mitochondria. 32 In T lymphocytes, the numbers of mitochondria are tightly regulated by autophagy. 31 However, the enhanced autophagy observed in naive and activated c-FLIP L À / À T cells did not appear to affect the mitochondrial numbers in these cells (Supplementary Figure S10C) . In zVAD-treated L929 cells, excessive autophagy causes ROS accumulation by degrading catalase, the major ROS scavenger. 28 Whether the same mechanism applies to T cells remains to be determined. On the other side, altered RIP-1/RIP-3 activity may also lead to abnormal ROS production.
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Discussion
Here we reported that the loss of c-FLIP L in T cells resulted in dramatic cell death upon TCR stimulation. Although c-FLIP L has long been considered as an antiapoptotic protein, activated c-FLIP L -deficient T cells showed extensive necroptosis. More interestingly, although previous studies showed the occurrence of necroptosis when caspase 8 activity was completely inhibited, we observed both necroptosis and enhanced caspase 8 cleavage in c-FLIP L À / À T cells. Our results suggest that the antinecrotic and pro-apoptotic activities of caspase 8 might be independently regulated. The increased apoptosis and necroptosis observed in c-FLIP L À / À T cells were both Fas dependent. In contrast, naive c-FLIP L À / À T cells showed no defects in survival. Our findings demonstrate that c-FLIP L suppresses autophagy in both activated and resting T lymphocytes, and the enhanced autophagy observed in these cells is cytoprotective.
In activation was shown to induce necroptosis in zVAD-treated HaCaT keratinocytes. 7 Therefore, future studies should focus on deciphering the signaling pathway of necroptosis induction 2 The fact that c-FLIP L , caspase 8, and FADD are all involved in necroptosis regulation strongly suggests that the inhibition of RIP-1/RIP-3 occurs at the DISC. 15, 16 The interaction between pro-caspase 8 and c-FLIP L at the DISC leads to the cleavage of c-FLIP L to generate p43FLIP.
p43FLIP and c-FLIP L recruit RIP-1 to the caspase 8/cFLIP/ RIP-1 complex, and p43FLIP binds RIP-1 with higher affinity than do full-length c-FLIP L or caspase 8 in T lymphocytes. 24 Studies in human fibroblast cell lines showed that caspase 8 mediated the cleavage of RIP-1 to produce an inhibitory RIP-1 fragment. 23 It is possible that a similar inhibitory mechanism may occur in T lymphocytes: c-FLIP L may regulate RIP-1 activity by recruiting RIP-1 to the DISC for caspase 8-dependent degradation. In this model, without c-FLIP L , the recruitment of RIP-1 is blocked. Therefore, RIP-1 cannot be regulated by caspase 8 cleavage, leading to increased RIP-1 activity and necroptosis. This hypothesis is supported by the accumulation of RIP-1 protein in c-FLIP L À / À T cells without changes in RIP-1 mRNA levels. Furthermore, the loss of c-FLIP L protein causes enhanced caspase 8 activation and a subsequent increase in apoptosis in c-FLIP L À / À T cells (Figure 7) .
Autophagy is shown to be beneficial for cell survival in c-FLIP L -deficient T lymphocytes. Autophagy supports cell survival in many circumstances; this cytoprotective role of autophagy is especially important upon nutrient withdrawal. 37 In T lymphocytes, autophagy is indispensible not only for surviving growth factor withdrawal, but also for regulating the mitochondria and endoplasmic reticulum. 31, 38, 39 How autophagy promotes cell survival in c-FLIP L À / À T cells remains to be determined. In addition to clearing unwanted intracellular substances and providing energy, autophagy may benefit activated c-FLIP L À / À T cells in a more direct way: studies in cells resistant to apoptosis revealed that autophagy actively removed active caspase 8. 40 Whether T lymphocytes employ a similar mechanism must be addressed in further studies. In addition, it will be interesting to investigate whether the enhanced autophagy observed in naive c-FLIP L À / À T lymphocytes renders them more resistant to cell death.
Our study reveals that excessive ROS production contributes to cell death in c-FLIP L À / À T lymphocytes upon TCR stimulation. This finding is consistent with previous reports showing that ROS accumulation leads to necroptosis in zVAD-treated L929 cells. 25, 28 Mitochondria may serve as the site of ROS production because of increased Ca 2 þ flux and metabolic changes, in which RIP-1 activity is involved. 33 Studies in L929 cells suggested that increased ROS production occurs downstream of dysregulated autophagy. Whether enhanced autophagic flux in c-FLIP L -deficient T cells leads to excessive ROS production remains to be determined. Nevertheless, it is possible that the downstream effects of autophagy are both beneficial and harmful for cell survival, c-FLIP L is a key pro-survival factor at the nexus of apoptosis, necroptosis, and autophagy. T-cell responses are tightly controlled to avoid the generation and activation of autoreactive cells and excessive tissue damage. 41 The presence of redundant death pathways guarantees that active lymphocytes are removed to avoid autoimmunity. Further studies will focus on developing c-FLIP as a therapeutic target to induce T-cell death or to enhance T-cell survival in vivo with the goal of improving adaptive responses to pathogens.
Materials and Methods Animals. c-FLIP L
À / À mice were generated by crossing c-FLIP R bacterial artificial chromosome (BAC) transgenic mice 18 to c-FLIP f/f Lck-cre þ mice. 17 c-FLIP f/f littermates were used as wild-type controls. The animals were genotyped as previously described and used at 6-8 weeks of age. Animal usage was conducted according to the protocols approved by the Duke University Institutional Animal Care and Use Committee.
Cell culture. Single-cell suspensions were prepared from spleens or peripheral lymph nodes after red blood cell lysis. T lymphocytes were enriched using an EasySep mouse T cell negative enrichment kit from StemCell Technologies (Vancouver, BC, Canada) according to the manufacturer's instructions. Total splenocytes or T lymphocytes were cultured in complete RPMI-1640 medium containing 10% FBS at 37 1C in the presence of 5% CO 2 for the indicated periods of time. For TCR stimulation, total splenocytes were stimulated with soluble anti-CD3 (2C11, 5 mg/ml, unless otherwise indicated in the figure legends). Anti-CD28 (clone 37.51, 2 mg/ml; BioLegend, San Deigo, CA, USA) was added to the cultures as indicated in the figure legends. Enriched T lymphocytes were activated with plate-bound anti-CD3 and anti-CD28. Some lymphocyte cultures were treated with 10 mM zVAD (Sigma, St Louis, MO, USA), 10 mM zIETD (BD Pharmingen, San Diego, CA, USA), 2 mg/ml anti-FasL (2MFL3, BioLegend), 100 nM Nec-1 (Enzo Life Science, Farmingdale, NY, USA) and 10 mM NAC as indicated in the figure legends.
Flow cytometry analysis. Single-cell suspensions were prepared from spleens and lymph nodes after red blood cell lysis, or from T lymphocytes that were cultured for the indicated periods of time. The cells were incubated with an FcR-blocking antibody (2.4G2), stained with FITC-, PE-, PE/Cy5-, APC-, APCCy7-, or Pacific Blue-labeled mAbs on ice for 20 min, and washed with FACS buffer (2% FBS, 0.02% NaN 3 in PBS). A total of 0.5-20 Â 10 5 events were collected on a FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed using FlowJo software (Tree Star, Ashland, OR, USA). All fluorescence-labeled Abs, including anti-CD3, anti-CD4, anti-CD8, anti-TCR-b, anti-CD19, anti-FasL, and anti-Fas, were obtained from BioLegend. To stain cell surface FasL, the cells were cultured with 1 Â protease inhibitor (Aprotinin; Sigma) for 4 h immediately before staining.
Cell death assays. For Annexin V staining, the cells were first stained for surface markers following the methods described above. The cells were then incubated with Annexin V-PE (BD Biosciences) and 7-AAD (BD Biosciences) in Annexin V-binding buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) for 15 min at room temperature. The cells were then diluted in Annexin V-binding buffer and analyzed within 1 h. For mitochondrial outer membrane permeabilization (MOMP) staining, the cells were incubated with 40 nM TMRE at 37 1C for 20 min and then stained with surface marker and 7-AAD (Invitrogen, Grand Island, NY, USA) in FACS buffer on ice for 15 min. The cells were washed with FACS buffer, incubated on ice, and analyzed immediately.
Cell proliferation assays. CFSE-labeled (Molecular Probes, Grand Island, NY, USA) splenocytes were stimulated with anti-CD3 (2C11, 5 mg/ml) in the presence or absence of anti-CD28 (clone 37.51; BioLegend, 2 mg/ml) for 3 days. Proliferation was assessed by measuring CFSE dilution in 7-AAD À CD4 þ or CD8 þ T cells by flow cytometry.
ROS and mitochondrial analysis. Splenocytes were cultured in the presence or absence of anti-CD3 (5 mg/ml, 2C11) for 16 h before staining.
Single-cell suspensions were incubated with 2.5 mM CM-H 2 DCFDA (Invitrogen) in DPBS at 37 1C for 15 min or 100 nM MitoTracker Green (Invitrogen, Molecular Probes) in RPMI-1640 medium for 30 min. The cells were washed with RPMI-1640 medium and stained with anti-CD4-APC, anti-CD8-APC/Cy7, and 7-AAD, and then washed with FACS buffer and analyzed by FACS immediately.
Western blot. For activated T cells, total splenocytes were cultured for 16-18 h with anti-CD3 (2C11, 5 mg/ml) before purification. T cells were purified using an EasySep mouse T cell enrichment kit (StemCell Technologies) according to the manufacturer's instructions. Cell purity was determined by flow cytometry to be 495%. Purified T-cell lysates were prepared in sample buffer (50 mM Tris-Cl (pH 6.8), 50 mM 2-ME, 2% SDS, 0.2% bromophenol blue, and 10% glycerol). Antibodies used for western blots were anti-c-FLIP (clone Dave- Fluorescent microscopy. Primary T lymphocytes were enriched using an EasySep mouse T cell enrichment kit (StemCell Technologies) according to the manufacturer's instructions. The cells were first stained with Cy3-, FITC-, and Pacific Blue-labeled anti-rabbit IgG, anti-CD4, and anti-CD8 and then stained with anti-LC3 (P015, MBL, Woburn, MA, USA). All images were captured with a custom-built Zeiss Observer D1 using a Zeiss 3100 objective lens (Zeiss, Thornwood, NY, USA) and a 1.4 numerical aperture. Images were captured using a Photometrics Cool SNAP HQ2 (Tucsan, AZ, USA) and analyzed using Metamorph software (Molecular Devices, Sunnyvale, CA, USA). The images were blindly deconvoluted (40 iterations). Positive staining for LC3 was defined as 4180% of background signal. LC3 puncta were defined as any enclosed LC3-positive area no smaller than 10 pixels.
Transmission electron microscopy. Live naive T lymphocytes were sorted into CD4 þ CD44 low 7-AAD À or CD8 þ CD44 low 7-AAD À populations. For sorting of activated T cells, total splenocytes were cultured with anti-CD3 (2C11, 5 mg/ml) for 18 h before activated cells were sorted into CD4 þ 7-AAD À or CD8 þ 7-AAD À populations. The cells were fixed in 4% gluteraldehyde in 0.1 M sodium cacodylate overnight and then pelleted and embedded in 2.5% molten agar and transferred into fresh fixative. The embedded cells were incubated in fresh fixative for a period of 1 h to overnight. The specimens were rinsed twice with 0.1 M sodium cacodylate buffer and postfixed in 1% osmium tetroxide for 90 min. The specimens were then rinsed again in sodium cacodylate buffer and dehydrated through an ethanol series (50, 70, 95, 95, 100, 100%) and placed in two changes of a transitional solvent (propylene oxide). The specimens were then placed in a 1 : 1 mixture of propylene oxide/epoxy resin 812 overnight before being placed in epoxy 812 for 1 h and embedded. The blocks were polymerized in a 60 1C oven overnight. Ultrathin sections (90 nm) were cut with a Reichert-Jung Ultracut E ultramicrotome, (Depew, NY, USA) placed on copper grids, and stained with uranyl acetate and Reynolds' lead citrate. The specimens were viewed with a Phillips CM 12 transmission electron microscope equipped with an AMT XR-100 2Vu digital camera system (Woburn, MA, USA).
Fragmented DNA release assay. Four-week-old mice were injected i.p. with 1-1.5 mg BrdU per animal per day for 2 weeks. Over 90% of the peripheral T lymphocytes were labeled with BrdU by the end of the injection period. The kinetics of fragmented DNA release were analyzed using a Cellular DNA Fragmentation ELISA kit (Roche Applied Science, Indianapolis, IN, USA) following the manufacturer's instruction.
In vitro inducible deletion. Splenocytes were cultured with 200 nM 4-OHT (Sigma-Aldrich, St Louis, MO, USA) for 3 days in the presence of IL-7 (1 ng/ml; PeproTech, Rocky Hill, NJ, USA). Live cells were purified after deletion using Ficoll (Sigma). 
